In childhood cancer survivors, an increased chance of the 2nd neoplasm, especially meningiomas, continues to be claimed in individuals addressed with somatropin after their first neoplasm, especially those that have been treated with cranial radiation. Children with specified rare genetic causes of limited stature have an increased risk of establis